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STUDY OF AUTOIMMUNE DISEASE IN NEW ZEALAND MICE
III. MECHANISMS UNDERLYING HEMOLYTIC ANEMIA OF NZB MICE*
IRWIN M. BRAVERMAN, MD.i- AND JANICE SLESINSKI, B.S.
Coornbs' positive (DC+) hemolytic anemia
is the main feature of autoimmune disease in
the NZB mouse. Antinuclear factor (ANF) and
L.E. cell phenomella are the important sero-
logical abnormalities in the NZB/NZW hybrid.
In previous studies we reported on the
genetic features and natural history of auto-
immune disease in these strains (1) and at-
tempts to transfer disease by parabiosis (2).
The present study offers evidence that Coombs'
positivity is not the prime factor underlying
the henmlytic anemia. In additiofl, experi-
merits will be described in which Coombs' posi-
tivity and hemolytic anemia have been induced
in Coombs' negative (DC—) NZB mice by
splenic cells and other tissue suspensions from
syngeneic and allogeneic mice. Transfer of
ANF between NZB/NZW hybrids by splenic
cell suspensions has also been accomplished.
MATERIALS AND METHODS
Animals. The source, breeding and care of the
NZB and F1 NZB/NZW hybrids have been de-
scribed previously (1, 2). Swiss ICR mice, specific
pathogen free, (Charles River Laboratories) and
CBA mice (Jackson Laboratories) were also used
in these experiments.
Hernatologic Studies. Blood was collected from
the retro-orbital venous plexus or tail vein. Micro-
hernatocrjts were determined by standard tech-
niques and reticulocyte counts were performed
using New Methylene Blue as stain.
Direci Coombs' Test. The test was carried out
in [0 >< 75 mm test tubes by conventional tech-
niques using goat antimouse gamma globulin(ilyland) for Coombs' reagent as previously de-
scribed (2).
Aniinuclear Factor. Nuclei of leucocytes in blood
smears of Swiss mice fixed in absolute ethanol
for 10 minutes served as the nuclear antigen. The
immunofluorescent procedure was carried out as
previously described (2).
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Histologic Methods. Tissues were fixed in 4%
buffered formalin and stained by conventional
techniues.
Red Cell Survival. The technique of Lindsey
et al. was employed (3). Sixty to 70 microliters
of blood were obtained from the retroorbital
venous plexus and mixed with 2 ml of pH 7.2
phosphate buffered saline (PBS) containing 2.5
i.u. of heparin. Eight to 10 microcuries of Na2
51CrO4 (Squibb) was added to the suspension which
was incubated for 3Q minutes at room tempera-
ture. After 3 washes in waim PBS (37°C) the
red cells were resuspended in a volume of 0.5 ml
PBS and injected into the tail vein.
Disposable calibrated glass micro-pipettes were
used to collect the radioactive blood samples at 1,
4, 7, 10 and 15 days after the labelled cells had
been injected. Forty microliters were collected
each time and the pipettes containing the samples
were wrapped in Parafilm® and Saran wrap®. All
samples were saved and counted together at the
end of the collection in a Picker Spectroscaler III
well type scintillation counter. The counts per
minute corrected for background were expressed
as a percentage of the 24 hour sample and plotted
on semilogarithm paper. The half-time (T ½)
disappearance of radioactivity was calculated by
graphic analysis The counts per minute were 80
to 5Q times background.
The following studies were performed: T ½
was determined for Swiss ICR and NZB mice.
The reticulocyte counts of individual NZB mice
was correlated with the half-life of autologous red
cells. Coombs' positive red cells from NZB mice
exhibiting hemolytic disease were labelled with
51Cr, injected into 4 week old (DC—) NZB mice
and red cell survivals calculated. Vice versa,
(DC—) red cells, labelled with 510r, from 4 week
old NZB mice were injected into (DC+) NZB
animals with hemolytic anemia and P ½ deter-
mined. Coombs' positive and (DC—) radiolabelled
red cells from old and young NZB animals re-
spectively were injected into 10 week old Swiss
ICR mice and the T ½ calculated.
Pardbio tic studies. Seven to twelve month old
(DC-i-) NZB mice exhibiting hemolytic anemia
were parabiosed to 4—6 week old (DC—) NZB ani-
mals as described previously (2). The animals
were separated on the fifth or sixth day and a red
cell survival was performed in each parabiont
with its own red blood cells. In one group of ani-
mals the duration of the (DC+) reaction in the
young parabiont was determined.
Transfer of disease with splenic cells and other
iissue suspensions. Tinder sterile conditions spleens
were cut into small pieces in Hanks' balanced
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salt solution and pressed through a 40 gauge wire
mesh. The cells were washed 3 times, an aliquot
counted in a hemnocytorneter chamber using 0.1% _______________ _______ _______________
HC1 as diluent and the final volume of the suspen-
sion adjusted to contain 0.5—1.5 >< 10 splenic cells
per ml. This number of cells was injected intra—
peritoneally into appropriate recipients. In other
experiments hepatic and renal cells were prepared
under similar conditions and injected into appro-
priate recipients. In some experiments, an equiv-
alent number of splenic cells or other tissue
suspensions were frozen and thawed three times
before injection into recipients. The recipients
were tested for the presence of Coombs' posi-
tivity or ANF, depending upon the experiment, at
varying intervals from four to 30 days after the
cells were injected.
Red cell survivals were determined in individ-
ual NZB recipients at 9 to 16 days depending
upon when they became (DC+), and the tests
were repeated in the same animals one month
later. _______________________________________________________
In the following experiments the recipients were
4—6 week old (DC—) NZB mice. Donor splenic
tissue came from 9—14 month old (DC+) NZB
mice exhibiting hemolytic anemia, 4—6 week old
(DC—) NZB mice and 10 week old CBA mice.
Other donor tissues included renal cells from the
same 9—14 month old (DC+) NZB animals and
CBA mice, and hepatic cells from CBA mice.
Donor cell suspensions were prepared from 1 or
2 animals and injected into groups of 2 to 3
recipients.
The following additional experiments were per-
formed as controls. One half ml of blood from
CBA mice, washed three times in PBS was in-
.jected intraperitoneally into NZB recipients.
Splenic cells from affected NZB mice were given
to NZW and Swiss ICR mice and splenic cells
from CBA mice were injected into Swiss ICR
animals. These transfer experiments are sum-
marized in Table I.
In analogous experiments, splenie tissue from
7—14 month old (ANF+) F1 NZB/NZW hybrids
was given to 4—6 week old (ANF—) hybrids. Swiss
ICR splenic, hepatic and renal cell suspensions
were also given to 4—6 week old (ANF—) hybrids.
Tests for ANF were performed at intervals from
4 to 30 days after the cells were injected.
RESULTS
Figure 1 shows the T ½ values of red cell
survivals in individual Swiss ICR and NZB
mice. A T ½ of less than 9 days is considered
abnormal. All the NZB mice were (DC+) and
a reticulocytosis of greater than 5% was as-
sociated will, a decreased red cell survival.
NZB mice, 4—6 weeks old and (DC—), had
T '/2 values identical to (DC+) animals with
reticulocyte counts less than 5%.
Coombs' positive red cells from NZB mice
TABLE I
Cell sus pension lran3fer experiments
Donor Tissue Recipient
,0if
. a
NZB (DC+)
NZB (DC—)
NZB (DC+)
CBA
CBA
CBA
CBA
CBA
NZB (DC+)
NZB (DC+)
spleen
spleen
kidney
spleen
liver
kidney
blood
spleen
spleen
spleen
NZB (DC—)
NZB (DC—)
NZB (DC—)
NZB (DC—)
NZB (DC—)
NZB (DC—)
NZB (DC—)
Swiss ICR
Swiss ICR
NZW
23/26*
10/19
3/6
6/19
6/6
5/6
0/8
0/6
0/8
0/8
* No. positive/no, tested.
exhibiting hemolytic disease had normal sur-
vival times in 4 week old NZB recipeints
(Fig. 1). Conversely, (DC—) red cells from 4
week old NZB mice had short T ½ values
in NZB animals with hemolytic disease. The
(DC+) and (DC—) NZB red cells behaved
identically in Swiss ICR mice, and for the
first 8 to 10 days, T ½ values were identical to
those found in Swiss ICR mice themselves.
Thereafter, antibodies to the NZB cells de-
veloped in the ICR mice and the red cells
were rapidly removed from the circulation.
In the parabiotic experiments between old
and young NZB mice, 20 pairs were followed
for 3 months. Iii 10 young parabionts, Coombs'
positivity could be detected for 6 to 12 weeks,
at which time the young NZB mice would
have been normally expected to develop a posi-
tive Coombs' reaction. The other 10 young
parabionts remained Coombs' positive for only
2 to 3 weeks. (CoonThs' positive red cells, with-
out radiolabel can be detected for 2 to 3 weeks
after injection into young NZB animals.)
In a number of these parabiotic pairs (Fig.
1) red cells survivals were performed in the
old and young parabionts on the sixth or
seventh day after separation. Accelerated dis-
appearance of red blood cells was not found in
the young parabionts even though they showed
a strongly Coombs' positive reaction.
Table I summarizes the data from experi-
ments in which splenic cells and oilier tissue
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RED CELL SURVIVAL
suspensions were used to transfer Coombs'
positivity and hernolytic disease to 4 week old
NZB animals. Red cell survivals were per-
formed in most of these animals and these data
are shown in Figure 2.
It was possible to transfer Coombs' positivity
and hemolytic disease to almost every re-
cipient with 0.5 to 1.5 x 10 splenic cells from
(I)C+) NZB mice exhibiting hemolytic dis-
ease. However, the interval between injection
of cells and detection of Coombs' positivity
ranged from S to 15 days and the duration of
the response lasted for only 2 to 3 weeks in
the majority of recipients. However, in several
mice the hemolytic phase lasted for only 1
week but the Coombs' positivity persisted for
2 to 3 weeks. When these recipients were ex-
amined one month later, the Coombs' reaction
had Thecome negative and the T ½ value rose
to the normal range in all animals. In 3 in-
stances, frozen and thawed splenic cells (F)
induced Coombs' positivity without hemolysis
iii recipient NZB mice while an equivalent
number of splenic cells not so treated pro-
duced hernolysis and Coombs' positivity in
recipients. The interval and duration of re-
sponse following the injection of frozen and
thawed cells was identical to that found with
viable splenic cells.
However, it was found that renal cells from
(DC+) NZB animals with hemolytic disease,
and splenic cells from 4—6 week old (DC—)
NZB mice also produced Coombs' positivity
in NZB recipients; but the T ½ value was
abnormal in only 2 recipients. Hepatic, splenic
and renal cells from CBA mice produced iden-
tical results in NZB recipients.
All these diverse cell suspensiotis produced
their effect after 8 to 15 days and the response
persisted for 2 to 3 weeks. When examined
one month later, all the recipients had become
(DC—) and the T ½ values had returned to
normal.
One half ml of CBA blood, washed three
times in saline and injected intraperitoneally
into NZB mice did not produce Coombs' posi—
tivity in the recipients. Splenic cells from CBA
mice injected into ICR mice did not produce
Coombs' positivity in recipient Swiss ICR
mice. And, splenic cell8 from affected NZB
mice produced no response in NZW and Swiss
ICR mice.
Although virtually all NZB aiiimals be-
come (DC+) and develop hemolytic anemia,
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we found six, 14 to 16 month old NZB mice
with a marked reticulocytosis of 20 to 60%
and anemia in the presence of a persistently
negative Coombs' test. We studied 2 of these
animals. Splenic cells from these (DC—) hemo-
tytic animals were able to induce Coombs'
positivity and hemolysis in NZB recipients
fter the usual interval, and the responses lasted
or 3 weeks.
Iii splenic cell transfer experiments between
ZB/NZW hybrids, ANF was found in only
/27 young recipients. The interval was 10 to
14 days and ANF was detected for only 1
o 2 weeks in the recipient.
Splenic cells from young (ANF—) NZB/
ZW hybrids and Swiss ICR mice did not
aduce ANF in NZB/NZW hybrids.
Renal lesions were not accelerated or pro-
luced in either NZB or NZB/NZW hybrids
jected with splenic cells from their respec—
ive isogeneic donors.
DISCUSSION
Our observations on the natural history of
utoimmune disease in NZB mice had sug-
sted that Coombs' positivity was not synony—
mous with hemolytic anemia in the NZB mouse
and that a factor other than a positive Coombs'
test was responsible for the hemolytic state.
Coombs' positivity preceded the appearance of
hemolytic anemia by 1 to 5 months. There
was no correlation between the strength of the
Coombs' reaction and the T ½ value. (The
reticulocyte count proved to be a good screening
test for the presence of hemolysis) Finally,
in a few animals hemolysis was present in the
absence of a positive Coombs' test. The present
studies support the belief that Coombs' posi-
tivity is not a prerequisite for the hemolytic
state. Coombs' positive red cells have normal
survival times in non-hemolytic NZB mice and
in Swiss ICR mice, but (DC—) red cells are
rapidly removed from the circulation when
introduced into hemolytic NZB animals. The
presence of gamma globulin on these red cells
is not sufficient condition to bring about their
increased destruction and the shortened sur-
vival times appear to be related to the re-
activity of the host. These studies confirm
similar findings reported by Lindsey et al. (3).
Several investigators have been successful in
transferring Coombs' positivity to young NZB
AUTOIMMUNE DISEASE IN NEW ZEALAND MICE
TRANSFER OF HEMOLYTIC DISEASE
RECIPIENTS: 4-6 week NZB (DC-) MICE
= DC+ 0= DC— F non-viable cells
277
T 2
DAYS
20
8
6
'4
2
I0
8
6
4
2
08'OSF0
o0
OF
•
FF
•.o 00
•IP 0•0•.oFF
S.S.
•
..
..
.
• ..
..
0 •0
0
o00
.
0
SF
..
••
S.
..S.
S.
NZB NZB CBA CBA CBA NZB NZB NZB
(DC-f-) (DC-)
IO-I2mos 4-6 weeks
(DC+)
O-2mos
(DC+)
RETIC
(DC-i-)
RETIC
SPLEEN SPLEEN SPLEEN UVER DNEY <1DNEY <5% >5%
I
DONOR TISSUES
FIG. 2
CONTROLS
278 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
mice with splenic cells from affected NZB ani-
mal (4, 5, 6, 7). Tn the studies by Holmes
ci al. (4, 5), the interval between injection of
splenic cells and detection of Coombs' positivity
in the recipients was 1 to 3 weeks and the re-
sponse lasted 4 to 5 weeks. In a few animals
the positive Coombs' test persisted until the
time the recipient would have been expected to
develop a positive test spontaneously. In the
experiments by Holborow and Denman (7) the
interval was 10 to 21 days and the duration 2
to 5 weeks. In our study the interval was S
to 15 days and the duration 1 to 3 weeks.
Adoptive immunity has been favored as the
mechanism involved in these transfer experi-
ments. The brief duration of the transferred
Coombs' positivity has been ascribed to a loss
of antigenic stimulation toward the donor cells
(4, 5, 7). Holmes suggested that the strain
may not be completely isogeneic and the trans-
ferred cells were rejected (4)
Our data however indicate that adoptive
immunity is not the mechanism. Contrary to
the finding of Holmes et at. (4, 5), we were
able to produce Coombs' positivity in NZB
recipients by injecting them with (DC—) NZB
splenic cells. In addition (DC+) NZB renal cell
suspensions, and frozen and thawed splenic
cells from (DC-F) NZB mice were also capable
of producing this response. Viable and non-
viable hepatic, splenic and renal cell suspensions
from CBA mice were also effective.
In control experiments, red cells from CBA
mice did not evoke Coombs' positivity in NZB
recipients, thus eliminating the possibility that
red cells in the hepatic, splenic and renal cell
suspensions from CBA mice were responsible
for producing Coombs' positivity in the NZB
recipients. Splenic cell suspensions from CBA
mice did not produce Coombs' positivity in
Swiss ICR mice, and splenic cells from (DC+)
NZB mice were ineffective on transfer to NZW
and Swiss ICR mice.
Our data are compatible with the hypothesis
that the recipient's lymphoid system is being
stimulated to produce the Coombs' positivity
and hemolytic anemia. The appropriate anti-
gens may be present in the splenic and renal
cell suspensions of NZB mice. The brief nature
of the recipient's response is compatible with
this hypothesis.
The CBA tissues may carry antigens which
cross react with the NZB antigens. Or, CBA
tissues may stimulate the recipient's lymphoid
system with factors that are immunologically
unrelated to NZB antigens, and thus trigger
the autoimmune process non-specifically.
The identical latent period and duration of
response in transfer experiments with NZB
and CBA tissues suggest that closely related
mechanisms are operative.
The transfer experiments with CBA tissues
also suggest that there are clones of lymphoid
cells in 4 to 6 week old NZB mice already
committed to produce autoimmune phenomena
and are waiting for the appropriate stimuli to
become active.
On the possibility that reticulo-endothelial
stimulation might cause these committed cells
to proliferate and produce Coornbs' positivity,
complete Freund's adjuvant was injected sub-
cutaneously and intraperitoneally into 2 and 4
month old (DC—) NZB mice. However, the
results were negative.
These transfer studies also indicate that
splenic cells from (DC+) NZB mice contain a
factor responsible for the hemolytic process
that is not present in the splenic cell suspen-
sions from (DC—) NZB mice.
In transfer experiments with splenic cells
from two old (DC—) NZB mice with hemo-
lytic anemia, it was possible to produce
Coornbs' positivity and hemolytic anemia in
NZB recipients. In another experiment splenic
cells were transferred from two 14 month old
(DC+) NZB mice without hemolytic anemia
to young NZB recipients. In both instances
the recipients became Coombs' positive but had
a normal red cell survival. These two studies
also support the belief that hemolytic anemia
and Coombs' positivity are produced by dif-
ferent factors.
AM' was detected in NZB/NZW hybrids
less frequently after splenic cell transfers. The
latent period was similar but the duration of
response shorter than in the NZB experiments.
Hepatic, splenic and renal cell suspensions from
Swiss ICR mice were not effective in stimulat-
ing the NZB/NZW hybrids to produce ANF.
Fruend's adjuvant given subcutaneously and
intraperitoneally to two and four month old
hybrids also was ineffective.
In previous parabiotic experiments with
NZB/NZW mice it was not possible to ac-
celerate autoimmune disease (2). In these ex-
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periments, ANF was transferred to some young
NZB/NZW parabionts and was detected for 1
to 2 months; however, clinical disease was not
produced. In the current parabiotic experiments
with NZB mice, Coombs' positivity has per-
sisted for 6 to 12 weeks in some young para-
bionts without hemolytic anemia. In none of
these experiments has renal disease been ac-
celerated or produced. The results from these
parahiotic experiments also may be attributable
to stimulation of young parabiont lymphoid
tissue by antigens from the older parabiont.
SuMMARY
Hemolvtic anemia and Coombs' positivity in
NZB mice appear to he related to different fac-
tors. A positive Coombs' test precedes hemoly-
sis by 1 to 5 months, and there is no correlation
between the strength of the Coombs' reaction
and the decreased red cell survival. The sur-
vival of Coombs' positive NZB red cells is
normal in Coombs' negative NZB animals and
in Swiss ICR mice. Coombs' positivity and
hemolytic anemia can be produced in young
NZB recipients by injection of diverse syn-
gencic and allogeneic cell suspensions. Stimu-
lation of the recipient's lymphoid system, rather
than adoptive immunity may be operative in
these transfer experiments. It has also been
possible to transfer ANF to young (ANF—)
NZB/NZW hybrids with splenic cells from old
(ANF±) NZB/NZW mice.
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